JCRB0406 PLC/PRF/5
Cell information
Important Notice(s)Cell type:general cells (View Pricing Information)
JCRB No. | JCRB0406 | Cell Name | PLC/PRF/5 |
---|---|---|---|
Profile | hepatoma, HBs antigen-positive | Other Name | Alexander |
Animal | human | Strain | |
Genus | Homo | Species | sapiens |
Sex | M | Age | 24 |
Identity | available | Tissue for Primary Cancer | liver, gallbladder |
Case history | malignant liver cancer with HBsAg positive. | Metastasis | No |
Tissue Metastasized | Genetics | Loss of D & G group chromosomes, with marker chr. | |
Life Span | infinite | Crisis PDL | |
Morphology | epithelial-like | Character | G6PD=Type A. Tumors developed in hamster(imn.sup). |
Classify | tumor | Established by | Alexander,J.J. |
Registered by | Sato,J. | Regulation for Distribution | Not regulated |
Comment | Grow in serum free medium. HBs antigen produced. | Year | |
Medium | Dulbecco's modified Eagle's medium with 10% heat inactivated fetal bovine serum. | Methods for Passages | Cells are rinsed once with PBS(-) and treat with 0.2% trypsin and 0.02 % EDTA. |
Cell Number on Passage | 4 x 10^4 cells/cm^2 | Race | |
CO2 Conc. | 5 % | Tissue Sampling | liver |
Tissue Type |
Detection of virus genome fragment by Real-time PCR | |||||||||
---|---|---|---|---|---|---|---|---|---|
Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
EBV | - | HBV | + | HIV-1 | - | HTLV-2 | - | ||
HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
BKV | - | HIV-1 | - | ||||||
JCV | - | HIV-2 | - | ||||||
ADV | - | HPV18 | - | ||||||
Notes | HB virus genome fragment was detected by realtime PCR. However, viral particles were not found (Br. J. Cancer, 34: 509 515 (1976)) in this cell line. In addition, this cell line has not been reported to produce HBV. The infectious HBV particles will not be produced by this cell line. |
Reference | |
---|---|
Pubmed id:63998 | Establishment of a continuously growing cell line from primary carcinoma of the liver. Alexander JJ,Bey EM,Geddes EW,Lecatsas G S Afr Med J. 1976 Dec 18;50(54):2124-8 |
Pubmed id:187208 | Hepatitis B surface antigen produced by a human hepatoma cell line. MacNab GM,Alexander JJ,Lecatsas G,Bey EM,Urbanowicz JM Br J Cancer. 1976 Nov;34(5):509-15 |
Images |
---|
Movies |
---|
LOT Information
Cell No. | JCRB0406 | Cell Name | |
---|---|---|---|
LOT No. | 02262010 | Lot Specification | distribution |
Medium | Dulbecco's modified Eagle's medium with 10% fetal bovine serum (GIBCO Cat. # 10099) | Temperature | 37 C |
Cell Density at Seeding | 2.9 - 3.4 x 10^4 cells/ml | Methods for Passages | Cells were harvested after treatment with 0.25% trypsin and 0.02% EDTA. |
Doubling Time | approx. 42 hrs | Cell Number in Vial (cells/1ml) | 9.6 x 10^5 |
Viability at cell freezing (%) | 94.4 | Antibiotics Used | free |
Passage Number | P70 | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type A), MD. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Yes | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - DMEM | CO2 Conc. | 5% |
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB0406 | Cell Name | PLC/PRF/5 |
---|---|---|---|
LOT No. | 02122010 | Lot Specification | distribution |
Medium | DMEM(GIBCO) with 10% heat inactivated fetal bovine serum(SIGMA027K03911) | Temperature | 37 C |
Cell Density at Seeding | 1.3-2.5x10^4 cells/sq.cm | Methods for Passages | Cells were harvested after treatment with 0.25%trypsin(GIBCO) and 0.02% EDTA. |
Doubling Time | NT | Cell Number in Vial (cells/1ml) | 2.2x10^6 |
Viability at cell freezing (%) | 91.8 | Antibiotics Used | free |
Passage Number | p71 | PDL | NT |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | NT |
Chromosome Mode | NT | Chromosome Information | NT |
Surface Antigen | NT | DNA Profile (STR) | D5S818:12 D13S317:11,12 D7S820:9,11 D16S539:13 VWA:15,16 TH01:7,8 AM:X TPOX:8 CSF1PO:10 |
Adhesion | Yes | Exoteric Gene | NT |
Medium for Freezing | Cell Banker BLC-1(Nihon Zenyaku Industries) | CO2 Conc. | 5 % |
Viability immediately after thawing (%) | Additional information |
Images |
---|
Cell No. | JCRB0406 | Cell Name | |
---|---|---|---|
LOT No. | 01272003 | Lot Specification | distribution |
Medium | Dulbecco's modified Eagle's medium with 10% fetal bovine serum (FBS lot; BioWhittaker 0S069F) | Temperature | 37 C |
Cell Density at Seeding | 3-10 x 10^4 cells.ml | Methods for Passages | 0.25% trypsin and 0.02% EDTA in Ca, Mg-free PBS |
Doubling Time | 37 hrs | Cell Number in Vial (cells/1ml) | 1.0 x 10^6 |
Viability at cell freezing (%) | 79 | Antibiotics Used | free |
Passage Number | P70 | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type A), LD. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Yes | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS in DMEM | CO2 Conc. | 5% |
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB0406 | Cell Name | PLC/PRF/5 |
---|---|---|---|
LOT No. | 122195 | Lot Specification | distribution |
Medium | Dulbecco's modified Eagle's medium with 10% heat inactivated fetal bovine serum (Flow.0070893) | Temperature | 37 C |
Cell Density at Seeding | 3.8x10^4 cells/sq.cm | Methods for Passages | Rinsed cells once with PBS(-) and treated with 0.1% trypsin and 0.005% EDTA. |
Doubling Time | NT | Cell Number in Vial (cells/1ml) | 1.97x10^6 |
Viability at cell freezing (%) | 87.6 | Antibiotics Used | free |
Passage Number | P67 | PDL | NT |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | NT |
Chromosome Mode | NT | Chromosome Information | NT |
Surface Antigen | NT | DNA Profile (STR) | |
Adhesion | Yes | Exoteric Gene | NT |
Medium for Freezing | Culture medium with 5% DMSO. | CO2 Conc. | 5% |
Viability immediately after thawing (%) | Additional information |
Images |
---|
Cell No. | JCRB0406 | Cell Name | |
---|---|---|---|
LOT No. | 112097 | Lot Specification | distribution |
Medium | Dulbecco's modified Eagle's medium with 10% fetal calf serum (FCS lot; BioWhittaker 6M0121) | Temperature | 37 C |
Cell Density at Seeding | 4-5 x 10^4 cells/ml | Methods for Passages | 0.2% trypsin and 0.02% EDTA |
Doubling Time | Cell Number in Vial (cells/1ml) | 6.1 x 10^5 | |
Viability at cell freezing (%) | 86.0 | Antibiotics Used | free |
Passage Number | P70 | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type A), AST. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Yes | Exoteric Gene | |
Medium for Freezing | CO2 Conc. | ||
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB0406 | Cell Name | PLC/PRF/5 |
---|---|---|---|
LOT No. | 12142015 | Lot Specification | distribution |
Medium | Dulbecco's modified Eagle's medium (low glucose) with 10% heat-inactivated fetal bovine serum (FBS; GIBCO Cat. # 10091). | Temperature | 37 C |
Cell Density at Seeding | 5.3 - 7.6 x 10^4 cells/mL | Methods for Passages | Cells were harvested after treatment with 0.25% trypsin and 0.02% EDTA. Passage twice a week. |
Doubling Time | approx. 49 hrs | Cell Number in Vial (cells/1ml) | 2.3 x 10^6 |
Viability at cell freezing (%) | 95 | Antibiotics Used | free |
Passage Number | P71 | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | NT |
Chromosome Mode | NT | Chromosome Information | NT |
Surface Antigen | NT | DNA Profile (STR) | |
Adhesion | Yes | Exoteric Gene | NT |
Medium for Freezing | 10% DMSO, 20% FBS - DMEM | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 95 | Additional information |